Lucera Erick
CIK 0001697616
EVP, CHIEF FINANCIAL OFFICERDirector
Filings
25
Latest May 14, 2026
Issuers covered
6
Showing
25 of 25
Page 1
Track record
5 of 6 open-market trades scored (83% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 80% | +9.4% | +4.8% | +36.4% | -6.9% |
| 90 days | 4 | 50% | +8.3% | +11.5% | +25.7% | -15.5% |
| 180 days | 4 | 50% | -7.4% | -15.4% | +54.3% | -52.9% |
| 365 days | 4 | 25% | -25.6% | -47.7% | +70.3% | -77.3% |
Issuers
Companies where Lucera Erick has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XAIR | Beyond Air, Inc. | 8 | Nov 6, 2025 |
| EDIT | Editas Medicine, Inc. | 5 | Mar 27, 2025 |
| DYN | Dyne Therapeutics, Inc. | 4 | May 14, 2026 |
| BBLG | Bone Biologics Corp | 3 | Sep 20, 2023 |
| SABS | Sab Biotherapeutics, Inc. | 3 | Dec 18, 2025 |
| AVEO | Aveo Pharmaceuticals, Inc. | 2 | Jan 19, 2023 |
All filings
25 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|